Lukas Matter
Impact in
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Virology top 2%
- HIV Research and Treatment
Papers in
- Epidemiology 32
- Virology and Viral Diseases 9
- Cytomegalovirus and herpesvirus research 8
- Mycobacterium research and diagnosis 7
- Herpesvirus Infections and Treatments 5
-
- Tuberculosis Research and Epidemiology 6
- Co-authors
- Kurt Schopfer (18 shared papers)Thomas Bodmer (6 shared papers)Amalio Telenti (3 shared papers)Federica Marchesi (2 shared papers)Douglas Bruce Lowrie (1 shared paper)Stewart Thomas Cole (1 shared paper)M. Joseph Colston (1 shared paper)Daniel Germann (8 shared papers)
- Journals
- Journal of Clinical Microbiology (12 papers)The Lancet (4 papers)The Journal of Infectious Diseases (3 papers)Journal of Neurology (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Lukas Matter
69 papers receiving 3.1k citations
Lukas Matter's Hit Papers
Peers
Comparison fields: 5 of 126
- Infectious Diseases 1.7k
- Virology 278
- Epidemiology 1.8k
- Molecular Medicine 184
- Parasitology 179
Countries citing papers authored by Lukas Matter
This map shows the geographic impact of Lukas Matter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Matter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Matter more than expected).
Fields of papers citing papers by Lukas Matter
This network shows the impact of papers produced by Lukas Matter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Matter. The network helps show where Lukas Matter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas Matter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis Hit paper breakdown → | 1993 | 1109 |
| 2 | 1996 | 138 | |
| 3 | 2017 | 129 | |
| 4 | 1982 | 112 | |
| 5 | 1999 | 98 | |
| 6 | 1999 | 91 | |
| 7 | 1991 | 75 | |
| 8 | 1999 | 74 | |
| 9 | 2007 | 73 | |
| 10 | 1994 | 71 | |
| 11 | 1987 | 62 | |
| 12 | 2009 | 62 | |
| 13 | 1998 | 58 | |
| 14 | 2009 | 57 | |
| 15 | 1996 | 56 | |
| 16 | 1997 | 56 | |
| 17 | 1986 | 56 | |
| 18 | 1997 | 56 | |
| 19 | 1994 | 51 | |
| 20 | 2001 | 47 |
About Lukas Matter
Lukas Matter is a scholar working on Epidemiology, Infectious Diseases, Virology, Immunology and Parasitology, having authored 70 papers that have together received 3.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Virology and Viral Diseases (9 papers), Cytomegalovirus and herpesvirus research (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Mycobacterium research and diagnosis (7 papers), Tuberculosis Research and Epidemiology (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (278 citations), Epidemiology (1.8k citations), Molecular Medicine (184 citations) and Parasitology (179 citations). Lukas Matter has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Kurt Schopfer, Thomas Bodmer, Amalio Telenti, Federica Marchesi, Douglas Bruce Lowrie, Stewart Thomas Cole, M. Joseph Colston, Daniel Germann, John A. Wilhelm and D Germann. Their work appears in journals such as Journal of Clinical Microbiology, The Lancet, The Journal of Infectious Diseases, Journal of Neurology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.